NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE)’s sale to AbbVie Inc. for $45.00 per share in cash. If you are a Cerevel shareholder, click here to learn more about your rights and options.
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI)’s sale to Ascendent Capital Partners for $26.50 per share in cash. If you are a Hollysys shareholder, click here to learn more about your rights and options.
Icosavax, Inc. (NASDAQ: ICVX)’s sale to AstraZeneca for $15.00 per share in cash plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones. If you are an Icosavax shareholder, click here to learn more about your rights and options.
Codorus Valley Bancorp, Inc. (NASDAQ: CVLY)’s sale to Orrstown Financial Services, Inc. for 0.875 shares of Orrstown common stock for each share of Codorus common stock. Upon closing of the proposed transaction, Codorus shareholders will own approximately 44% of the outstanding shares of the combined company. If you are a Codorus shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
- Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results - May 14, 2025
- FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 14, 2025
- Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share - May 14, 2025
